Novavax is an American healthcare company that focuses on the creation and development of vaccines. It has offices in the US and Sweden. Novavax is a prominent company within the biotechnology industry, after completing many vaccine trials for illnesses such as Ebola, RSV and influenza. In particular, Novavax stock gained prominence during the Covid-19 pandemic, as it was one of the main contenders for an approved vaccination. The company is listed on the NASDAQ stock exchange and is also a constituent of the Russell 2000 stock index, which measures small-cap companies. View our holding costs, margin rates and trading hours below to start spread betting or trading CFDs on Novavax’s share price. See also Smith & Nephew (LSE:SN), Silverback Therapeutics(NASDAQ:SBTX), Pfizer(NYSE:PFE).